All data are based on the daily closing price as of June 27, 2025
o

Olympus

7733.TSE
11.25 USD
-0.28
-2.43%

Overview

Last close
11.25 usd
Market cap
12.68B usd
52 week high
19.88 usd
52 week low
11.24 usd
Target price
16.39 usd

Valuation

P/E
15.7977
Forward P/E
16.6667
Price/Sales
1.8365
Price/Book Value
2.4365
Enterprise Value
12.48B usd
EV/Revenue
1.8107
EV/EBITDA
7.7715

Key financials

Revenue TTM
6.89B usd
Gross Profit TTM
4.73B usd
EBITDA TTM
1.62B usd
Earnings per Share
0.71 usd
Dividend
0.14 usd
Total assets
9.61B usd
Net debt
-157.15M usd

About

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.
  • Symbol
    7733.TSE
  • Exchange
    TSE
  • Isin
    JP3201200007
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Medical Devices
  • CEO
    Stephen Kneebone
  • Headquarter
    Tokyo
  • Web site
    https://www.olympus-global.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top